![]() |
|
E. Vismara (1), M. Pierini (1), G. Mascellani (2), L. Liverani (2), M. Lima (3), M. Guerrini (4), G. Torri (4)
(1) Politecnico di Milano, Dipartimento di Chimica, Materiali e Ingegneria Chimica “G. Natta”, Milano, Italy; (2) OPOCRIN S.p.A., Corlo di Formigine (Modena), Italy; (3) Departamento de Bioquímica da Universidade Federal do Rio Grande do Norte, Brasil; (4) Istituto di Ricerche Chimiche e Biomediche “G. Ronzoni”, Milano, Italy
Hydrogen peroxide (H2O2) and Cu(OAc)2 or FeSO4 (Fenton type reagents) perform heparin (Hep) depolymerisation to low-molecular-weight heparin (LMWH) following a radical chain mechanism. Hydroxyl (OH) radicals which are initially generated from H2O2 reduction by transition metal ions abstract hydrogen atoms on the heparin chain providing carbon centred radicals whose decay leads to the depolymerisation process. The main depolymerisation mechanism involves Hep radical intermediates that cleave the glycosidic linkage at unsulphated uronic acids followed by a 6-O-nonsulphated glucosamine, thus largely preserving the pentasaccharide sequence responsible for the binding to antithrombin III (AT). Both the transition metal ions influence the overall efficiency of the radical chain processes: Fe2+ acting as a catalyst, while Cu2+ acts as a reagent. LMWHs, especially those afforded by Cu2+, are somewhat unstable to the usual basic workup. However, this lack of stability can be eliminated by a previous NaBH4 reduction. Furthermore, with Cu2+, the process is much more reproducible than with Fe2+. Therefore, for the process of Fenton type depolymerisation of heparin, the use of Cu(OAc)2 is clearly preferable to the more “classical” FeSO4. The resulting activities and characteristics of these LMWHs are peculiar to these oxidative radical processes. In addition, LMWH provided by H2O2/Cu(OAc)2 in optimised conditions was found to posses anti-Xa and anti-IIa activities comparable to those of LMWHs currently in clinical use.
LMWH, Heparin radical, Fenton type reaction, transition metal ions, NMR
| 1. | ||
H. Partsch Phlebologie 2003 32 2: 29-36 | ||
| 2. | ||
Norma Maugeri1, Giovannina Di Fabio1, Miriam Barbanti2, Giovanni de Gaetano1, Maria Benedetta Donati1, Chiara Cerletti1 Thrombosis and Haemostasis 2007 97 6: 965-973 http://dx.doi.org/10.1160/TH06-12-0680 | ||
| 3. | ||
Konstantinos Konstantinidis1, Thomas Gerasimidis1, Elisabeth Verdy2,3, Ismail Elalamy2,3, Michel M. Samama3,4, Grigoris T. Gerotziafas2,3 Thrombosis and Haemostasis 2007 97 1: 109-118 http://dx.doi.org/10.1160/TH05-10-0701 | ||